Streamlining MEDITECH Fasenra Prior Authorization

Klivira automates the complex MEDITECH Fasenra prior authorization process, integrating directly with your EMR to reduce administrative overhead and accelerate patient therapy initiation.

Managing prior authorizations for high-volume specialty medications like Fasenra within a diverse EMR environment such as MEDITECH presents unique operational challenges. Revenue cycle directors and prior authorization coordinators face manual data entry, fragmented workflows, and delays that impact patient care and financial performance. Klivira provides a targeted solution to these complexities.

The Challenge of Fasenra Prior Authorization in MEDITECH Environments

Fasenra, a biologic medication, frequently requires prior authorization across commercial, Medicare Advantage, and Medicaid managed care plans, making it a high-volume target for PA workflows. Integrating these complex requirements into MEDITECH's varied product lines—from legacy Magic and C/S to modern Expanse—demands a nuanced approach to avoid delays and denials. Klivira understands these distinctions, offering a tailored solution for your specific MEDITECH deployment.

Klivira's Integration with MEDITECH for Fasenra PA

Klivira leverages MEDITECH's integration surfaces, primarily focusing on Expanse APIs and FHIR R4 capabilities, to embed prior authorization workflows directly into the EMR. For customers utilizing MEDITECH Expanse, our solution can integrate via SMART App Launch, providing a seamless, context-aware experience from the clinical desktop. For legacy MEDITECH environments, we support established HL7 v2 interfaces, ensuring comprehensive coverage across your entire footprint.

Key Touchpoints for Fasenra PA Workflows in MEDITECH Expanse

**Orders Activity**: Initiate Fasenra orders, triggering the integrated prior authorization process directly within the clinician's workflow.
**Patient Summary / Storyboard**: Access at-a-glance PA status updates and relevant clinical context for Fasenra.
**Documentation**: Automatically deposit submitted PA packets and approval letters as attachments within the patient's chart.
**Surveillance / Worklists**: Route PA-status follow-up items and tasks for Fasenra directly to relevant staff.
**Communication / Messaging**: Facilitate internal and external communications related to Fasenra prior authorization.

Optimizing Documentation for Fasenra Prior Authorization

Effective prior authorization for Fasenra relies on robust clinical documentation. Klivira intelligently extracts necessary data from MEDITECH's clinical notes, problem lists, medication histories, and diagnostic results to build a comprehensive PA packet. This automation reduces the manual burden on PA coordinators, ensuring all required medical necessity criteria are addressed for both pharmacy and medical benefit determinations, regardless of whether Fasenra is billed under the medical or pharmacy benefit.

Navigating Fasenra's Medical and Pharmacy Benefit PA

Fasenra, like many specialty biologics, can fall under either the medical or pharmacy benefit depending on the payer and site of care. Klivira's platform is engineered to distinguish between these pathways, routing the prior authorization request through the appropriate channel (e.g., X12 278 for medical benefit, NCPDP SCRIPT for pharmacy benefit or ePA portals). This critical capability ensures that the correct documentation and submission standards are met, minimizing delays.

MEDITECH Integration Mechanisms for Robust PA Automation

Klivira's integration strategy with MEDITECH is designed for resilience and adaptability. We leverage MEDITECH's modern Expanse APIs, including FHIR R4 for read access to US Core resources, and support SMART App Launch for embedded application experiences. Recognizing the continued operational importance of legacy systems, we also maintain robust support for HL7 v2 interfaces, ensuring critical ADT and ORM/ORU messages are captured for comprehensive prior authorization management across all MEDITECH product lines.

Frequently asked questions

How does Klivira handle the variability between MEDITECH Expanse and older product lines like Magic or C/S for Fasenra prior authorization?

Klivira explicitly accounts for MEDITECH's product-line variability. For Expanse, we leverage modern FHIR R4 APIs and SMART App Launch. For legacy systems, we integrate via established HL7 v2 interfaces. This ensures a consistent Fasenra prior authorization workflow across your entire MEDITECH footprint, adapting to the specific integration surfaces available at each deployment.

Can Klivira pull specific clinical data from MEDITECH to support Fasenra medical necessity criteria?

Yes, Klivira is designed to pull relevant clinical data from MEDITECH. This includes information from patient charts, problem lists, medication histories, and clinical notes, which are crucial for meeting Fasenra's medical necessity criteria. Our system aggregates this data to automatically build comprehensive prior authorization packets, reducing manual data extraction.

How does Klivira ensure Fasenra prior authorization requests are sent to the correct payer channel (e.g., medical vs. pharmacy benefit)?

Klivira's platform intelligently identifies whether Fasenra prior authorization falls under the medical or pharmacy benefit based on payer rules and billing context. We then route the request through the appropriate channel, utilizing standards like X12 278 for medical benefit PAs or NCPDP SCRIPT for pharmacy benefit ePA, ensuring compliance with payer-specific submission requirements.

Does Klivira's integration require a separate login for MEDITECH users?

For MEDITECH Expanse users, Klivira supports SMART App Launch, which facilitates a single sign-on (SSO) experience. This allows clinicians and PA coordinators to access Klivira directly from within their Expanse workflow without requiring separate credentials, maintaining context and streamlining user experience. For legacy systems, SSO patterns are typically managed via vendor-specific integration.

What kind of write-back capabilities does Klivira have for Fasenra PA status in MEDITECH?

Klivira aims to write back essential prior authorization status updates and documentation into MEDITECH. While write-back capabilities via FHIR are more limited than read across MEDITECH product lines and require customer-specific verification, we prioritize depositing critical artifacts like approval notifications or submitted PA packets as DocumentReference entries or within communication modules where supported.